epithalon amidate certificate of analysis Epitalon NA-Selank Amidate | Alpha Omega

This finding opens up new therapeutic avenues for patients with MC4R mutations or dysfunction, where conventional weight loss strategies may not be effective

Cagrilintide is NOT a GLP-1 peptide, but an amylin analog

AOD-9604's pivotal Phase 2b trial failed its primary endpoint: 536 participants, 24 weeks, no statistically significant fat loss versus placebo

works well so far My weight loss journey started in November of 2025, but came to a hault due to the pricing under my pcp

After 21 days, BW increased by 2.6% 0.71% in V rats and was reduced in the other cohorts by 8.7% 0.91% (CS), 5.6% 0.50% (PF) or 9.0% 0.42% (WM) (all P 3 C)